Animal Testing: Vioxx, 2005
Please note that some historical materials may contain harmful content and/or descriptions. Learn how we're addressing it.
Folder information
- Title:
- Animal Testing: Vioxx, 2005
- Description:
- This resource contains articles discussing the drug Vioxx and the links drawn between the drug and the increased risk heart attack stroke. It includes information about lawsuits filed against the drug company Merck, and the role the FDA played in approving the medication.
- Topics:
-
Animal Protection
- Subjects:
-
Animal welfare -- Law and legislation
Cardiology
Heart -- Diseases
Pain
Pharmaceutical policy
Rofecoxib
- Original Format:
-
Archival collection
- Item identifier:
- mc00236_2597354_20210401_10872
- Created Date:
- Names:
-
Merck & Co.
more info on Merck & Co.
Pfizer Pharmaceuticals more info on Pfizer Pharmaceuticals
United States. Food and Drug Administration more info on United States. Food and Drug Administration
- Digital Project:
-
Animal Turn
Source information
- Repository:
- Special Collections Research Center at NC State University Libraries
- Collection:
- Tom Regan Papers 1786-2016 (bulk 1966-2006) (MC00236) held by Special Collections Research Center at NC State University Libraries
- Note field:
- Not all materials from the physical collection may have been scanned. Images may have been enhanced for web access.
- Rights:
- For questions regarding copyright or permissions, please refer to our Reproduction, Use, Citation, and Copyright page (http://d.lib.ncsu.edu/collections/about).
- Funding:
- This resource was created with support from the Council on Library and Information Resources (CLIR), an independent, nonprofit organization that forges strategies to enhance research, teaching, and learning environments in collaboration with libraries, cultural institutions, and communities of higher learning. CLIR's Digitizing Hidden Special Collections and Archives awards program, which is generously supported by funding from The Andrew W. Mellon Foundation, supports the creation of digital representations of unique content of high scholarly significance that will be discoverable and usable as elements of a coherent national collection.